The optimal treatment of septic shock remains controversial. In order to evaluate the efficacy of fluid resuscitation and corticosteroid administration, the following experimental study was undertaken. Forty-five puppies (1.6-5.4 kg) were randomly divided into 9 groups generated by combining 3 different fluid regimens and 3 different timings for steroid administration. Arterial, venous, and pulmonary artery catheterization allowed continuous hemodynamic and metabolic monitoring. Septic shock was achieved by a slow bolus infusion of 109/kg Escherichia coli organisms. Methylprednisolonc (30 mg/kg) was administered either 30 min before bacterial infusion, at the time of shock, or 30 min after shock. When cardiac output dropped to less than 50% of control values, 1 of the 3 following fluid resuscitation regimens was begun: 5 % albumin in lactated Ringer's (LR) at 35 % of the estimated blood volume (EBV), LR at 105% EBV, or 5% albumin in LR at 105% EBV.
The optimal treatment of septic shock remains controversial. In order to evaluate the efficacy of fluid resuscitation and corticosteroid administration, the following experimental study was undertaken. Forty-five puppies (1.6-5.4 kg) were randomly divided into 9 groups generated by combining 3 different fluid regimens and 3 different timings for steroid administration. Arterial, venous, and pulmonary artery catheterization allowed continuous hemodynamic and metabolic monitoring. Septic shock was achieved by a slow bolus infusion of 109/kg Escherichia coli organisms. Methylprednisolonc (30 mg/kg) was administered either 30 min before bacterial infusion, at the time of shock, or 30 min after shock. When cardiac output dropped to less than 50% of control values, 1 of the 3 following fluid resuscitation regimens was begun: 5 % albumin in lactated Ringer's (LR) at 35 % of the estimated blood volume (EBV), LR at 105% EBV, or 5% albumin in LR at 105% EBV.
When all the groups were combined, early steroid treatment was more effective than delayed therapy, yielding respective survival rates of 47% and 7% at 180 rain. Similarly, the large-volume resuscitation groups achieved a 43% survival rate compared to 13% for the smaller fluid protocols. Neither early steroid therapy nor large volume fluid therapy was shown by itself to increase survival, however. Despite steroid pretreatment, none of the puppies given the lower-volume infusion survived. Also, despite large-volume fluid resuscitation, there were no survivors when this was combined with steroid treatment that was delayed 30 min. Only by combining early steroid administration with large-volume fluid therapy was a markedly A portion of this study was supported by a grant from the Upjohn Company, Kalamazoo, Michigan.
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A definite increase in animal survival has, therefore, been shown in the acute period of severe septic shock using a combination of high-volume fluid resuscitation and the early administration of steroids.
Septic shock continues to be a clinical state that causes significant rates of mortality. The optimal treatment of this pathological condition remains a matter of controversy. Questions about the efficacy of corticosteroid therapy in treating shock states continue to be part of this controversy. The use of fluid resuscitation and antibiotics has generally gained wider acceptance, however.
Evaluation of the relative importance of each component of therapy has been difficult. Many studies have poorly quantitated the volume and kind of fluid resuscitation used. The timing and type of steroid administration has also varied. The use of shock models of different types and variable severity has further complicated the evaluation of previous studies.
Several experimental models have suggested beneficial results from corticosteroids alone [1] [2] [3] , while others (including one from our laboratory) have shown no effect [4] [5] [6] . Other studies have suggested that steroid treatment must be combined with antibiotic therapy and fluid resuscitation to show a clear additional benefit [7, 8] .
Through the use of a puppy model of live Escherichia coli shock, identical to that used in our previous studies [5, 9] , this experiment combines carefully quantitated fluid resuscitation with a steroid administration protocol in order to assess the efficacy of a variety of combinations of these 2 modalities. 
Materials and Methods
Forty-five mongrel puppies (1.6-5.4 kg) were randomly divided into 9 groups. A subcutaneous injection of 50 ml/kg of normal saline ensured adequate hydration during a 12-hour fast before the experiment. Pentobarbital anesthesia (25 mg/kg) was given and femoral artery and vein catheterization was performed bilaterally. A pediatric thermal dilution cardiac output catheter was passed through the pulmonary artery, and each animal was heparinized with 400 IU/kg of beef lung heparin. Baseline hemodynamic and metabolic measurements were made and repeated at regular intervals during the experiment. Treatment protocols for the 9 groups are shown in Table 1 . Each puppy was subjected to a rapid infusion of 109 live E. coli (Dunwald strain B15:0125) per kilogram of body weight. Optical density measurements were made to determine the number of organisms infused. A 50% reduction in cardiac output was defined as shock. At the time of shock, each animal received fluid resuscitation. One of the 3 following treatments was used: lactated Ringer's (LR) at 105% of the estimated blood volume (EBV); 5% albumin in LR at 35% of the EBV; or 5% albumin in LR at 105% of the EBV. EBV was calculated as 7% of the puppy's weight. In addition, each puppy received 30 mg/kg of intravenous methylprednisolone sodium succinate (MPSS) either 30 min before bacterial infusion, at the time of shock, or 30 min after shock was documented. These combinations thus defined the 9 experimental groups seen in Table 1 . At the end of the 3-hour experimental period, the probability of long-term survival was assessed for each of the surviving animals. If the cardiac output was stable and measured at least 60% of the baseline value, long-term survival was predicted. The animals were sacrificed and correct placement of the pulmonary artery catheter was confirmed. Standard laboratory methods were used to measure plasma glucose, cholesterol, triglycerides, free fatty acids, lactate, acid phosphatase, and arterial blood gases. The Wilcoxon signed rank test and Student's t-test were used for analysis, with p values of less than 0.05 considered significant. Table 2 summarizes the general information about each group and lists the actual and predicted longterm survival. The 2 variables involved can be looked at individually and in combination. The first of these is the fluid resuscitation, and the second is the timing of the MPSS administration.
Results

Survival
The large-volume regimens, either with or without albumin, showed comparable survival results and each was statistically different from the smallervolume resuscitation groups. When groups were combined, puppies given 105% of their EBV (groups 1, 3, 4, 6, 7, and 9) showed a survival rate of 43% (Table 3) . Only 13% of the animals receiving 35% EBV treatment survived (groups 2, 5, and 8) ( Table 4) .
The second variable, the timing of MPSS administration, also brought about significant differences in survival rate. Steroid treatment 30 min after shock achieved only a 7% survival rate regardless of the type of fluid resuscitation ( Table 5 ). The survival rate for animals treated at the time of shock or pretreated with MPSS was 47% (Table 6 ). Despite pretreatment with MPSS, none of the smallvolume resuscitation puppies survived. The corn- Table 3 . Collected groups' survival: Large-volume fluid resuscitation. bined survival rate of puppies similarly treated with MPSS, but given large-volume resuscitation (groups 1 and 3) was 70% (Table 7) . Similar analysis showed that despite large-volume resuscitation in groups 7 and 9, there were no survivors when this treatment was combined with a delay in MPSS until 30 min after shock.
The groups receiving the combination of either steroid pretreatment or treatment at the time of shock with large-volume fluid resuscitation showed a 65% survival rate compared to only 8% for all other animals (Table 7) . Seventy percent of the steroid pretreated-high-volume fluid resuscitation group survived and 40% of these animals met criteria for predicted long-term survival at the completion of the experimental period (Table 8) . No other group yielded predicted long-term survivors.
Hemodynamic Studies
Cardiac output (CO) (Fig. 1 ) decreased significantly to less than 50% of control values in each group. Following fluid resuscitation, cardiac output increased markedly in each group. The best recoveries were seen with the larger-volume regimens, but differences were not statistically significant among groups. Following this initial improvement, outputs again deteriorated in each group of animals. Only in group 6 puppies, who were given high-volume 5% albumin in LR resuscitation and steroids at the time of shock, was the cardiac output (CO) clearly statistically still elevated above shock levels at 15 min after resuscitation. In the puppies pretreated with steroids and given large-volume fluid resuscitation, the rate of decline in CO was slowed. Each group given steroids after 30 min of shock showed statistically significant drops in CO 15-30 min following fluid administration. While all other groups showed some decline, these differences were not statistically significant. The group given LR resuscitation at 35% EBV and steroids at the time of shock had a more rapid decline of CO than the large-volume resuscitation group.
Mean blood pressures paralleled cardiac output measurements. Each group showed a recovery with fluid resuscitation. Only groups 1 and 3 (largevolume-steroid pretreatment groups) showed significant improvement in blood pressure when compared to the other animals. The improvement was short-lived in group 3 and slightly more sustained in group 1.
Pulse pressure decreased with the bacteremia in all the animals. There was an initial recovery with 
Metabolic Studies
In each group, there was a significant acidosis measured after bacterial infusion. Mean pH values decreased to 7.0 or less in each group. The highvolume-early steroid treatment groups 1 and 3 maintained blood pH better than the other groups, but this trend was statistically significant only at a few points during the experiment (Fig. 2) . Lactic acidosis was documented in each animal. Mean values for each group rose to at least 60 mg/100 ml by the time fluid resuscitation was given. There were few statistically significant differences among groups. Group 1 had significantly lower lactate levels than groups 5, 7, and 9 at 30 rain after resuscitation (Fig. 3) . Acid phosphatase levels rose significantly in each group. Variable responses were seen among the animals. There was a trend toward higher elevations in the low-volume groups, which reached statistical significance when groups 2 and 5 were compared to group 1 at 60 min (Fig. 4) .
Serum glucose levels were quite variable and showed consistent decreases only as animals entered profound shock (Fig. 5) . Group 2 did show a significant drop in values at 60 min. Cholesterol levels all decreased during the shock state. The magnitude of the change was not consistent, however, and no definite trends were identifiable. Free fatty acids showed little change, with only groups 2 and 3 showing early rises that were statistically significant. Serum triglycerides also showed no definite trends. Group 1 showed significant declines at 60 and 120 min and group 2 showed early significant elevations. Arterial PO2 and PCO2 were quite stable during the experimental period and showed no changes of statistical significance.
Discussion
The debate over the usefulness of corticosteroid therapy in shock has been active for many years and has remained largely unresolved. This study is directed at a specific area of that debate, namely, the usefulness of corticosteroids in the early phases of the treatment of severe (LDlo0) bacteremic shock. Significant differences have been noted between true bacteremic and pure endotoxin shock [10] . We believe that a bacteremia model more closely approximates human septic shock than the shock state produced by endotoxin alone.
Previous studies have provided evidence both for and against the efficacy of steroids in this type of shock. Herman et al. [6] showed no protection against diffuse intravascular coagulation and kinin release in E. coli shock in the baboon with steroid pretreatment. Our laboratory [5] showed no significant increase in survival, cardiac output, carbohydrate metabolism preservation, or cellular membrane stabilization when MPSS was used without fluid resuscitation as the only treatment of septic shock in puppies. Coalson et al. [4] showed no protection against the microscopic damage to the baboon liver, kidney, or adrenal glands with MPSS given 15 min after E. coli infusion. Hinshaw et al. have reported increased survival using a combination of MPSS and antibiotic therapy (gentamicin at 9 mg/kg) in both canine [8] and primate [7] E. coli shock. This difference in survival could not be shown for MPSS treatment alone, however. Sambhi and co-workers [11] have shown increased cardiac output and decreased peripheral resistance after dexamethasone treatment in controlled bacteremia in humans.
The experimental model used in this study has reliably produced lethal shock in untreated puppies in previous studies from our laboratory [5, 9] . The use of immature animals may more closely approximate clinical shock in the pediatric age range. The magnitude of bacteremia is comparable to that used in other published studies [12] . Three of the theoretical advantages of corticosteroid therapy were evaluated:the positive inotropic effect on the heart, lysosomal membrane stabilization, and carbohydrate metabolism preservation. The efficacy of small-and large-volume fluid therapy was also evaluated.
The large-volume fluid regimens were clearly superior to the smaller-volume resuscitation protocols. Combined survival rate of animals given highvolume resuscitation (105% of the EBV) was 43%. There were no statistically significant differences between the 5% albumin group and those not given albumin. In contrast, only 13% of the puppies receiving 35% of their EBV as resucitation survived. Steroid pretreatment or treatment at the time of shock was more effective than treatment delayed until 30 min after shock. The survival rate with each of these 2 treatments was 47%, compared to only 7% with delayed therapy. Neither large-volume fluid resuscitation nor early steroid treatment, however, was effective alone in increasing survival. When the more favorable largevolume fluid resuscitation was combined with delayed steroid treatment in groups 7 and 9, there were no survivors. Similarly, when the more effective early steroid treatment was combined with lowvolume fluid resuscitation in groups 2 and 5, only a 10% survival was achieved. It was only by combining large-volume fluid resuscitation with early corticosteroid treatment that increased survival resulted. Groups 1, 3, 4, and 6, which combined these variables, yielded a 65% survival rate compared to only 8% for all other groups. Groups 1 and 3, which were pretreated with steroids, showed a combined 70% survival rate.
The importance of this trend toward better survival with earlier steroid treatment is substantiated by looking at cardiac output values. Forty percent of the puppies given steroid pretreatment and highvolume resuscitation maintained cardiac outputs of greater than 60% of control values at the end of the experiment and were, therefore, predicted longterm survivors. No other surviving animals met this criterion.
The exact mechanism for the increased survival documented in this experiment cannot be proven from our present data. Strong trends were noted in the early steroid treatment-large fluid volume groups toward higher cardiac outputs, lower acid phosphatase levels, and less acidosis. At various points during the experiment, these trends reached statistical significance. The survival figures show clear statistical significance.
In conclusion, in this model, a definite increase in animal survival has been shown in the acute phase of severe septic shock using a combination of highvolume fluid resuscitation and the early administration of corticosteroids. 
R6sum6
Le meilleur traitement du choc septique pr6te encore/~ controverse. Pour le determiner, une 6tude exp6rimentale a 6t6 entreprise de mani6re ~ apprdcier l'efficacit6 de la compensation liquidienne et celle des corticoides. Pour ce faire, 45 chiots (1,6-5,4 kg) furent randomis6s en 9 groupes en combinant l'administration de 3 types de liquide et celles des st6ro~des ~t 3 moments diff6rents. Le cath6t6r-isme art6riel, veineux et celui de I'art6re pulmonaire permirent l'6tude continue de l'h6modynami-queet des m6tabolismes. Le choc septique fut provoqu6 par l'injection lente d'un bolus constitu6 de 109/kg d'E. Coli. Le m6thylprednisolone (30 mg/kg) fut employ6 30 minutes avant l'injection, au moment du choc ou encore apr6s le choc. D6s que le d~bit sanguin fut r6duit de la moiti6, la r6animation par apport liquidien fut assur6e suivant 3 protocoles diff6rents: injection de solution de Ringer enrichi de 5% d'albumine (35% du volume sanguin ou 105% du volume sanguin), solution de Ringer pur (105% du volume sanguin).
Les resultats furent les suivants: l'administration pr6coce des stdroides fut plus efficace que radministration tardive, se traduisant par un taux respectif de survie de 47% dans le premier cas et de 7% dans la seconde 6ventualit6. De faqon identique, rinjection importante de liquide se solda par un taux de survie de 43% alors que celui de l'injection limitde ne ddpassa pas 7%. Cependant, ni la corticoth6rapie pr6coce, ni la compensation liquidienne importante n'augmenta par elle-meme la survie. Aucun des chiots qui furent soumis ~t la corticoth6rapie pr6-coce mais ne requrent que peu de liquide ne surv6-cut. I1 en fut de meme lorsque le chiot rebut un apport liquidien important et fut soumis & la corticoth6rapie tardive. C'est seulement en combinant la corticoth6rapie prdcoce et un apport liquidien important que le taux de survie fut am61ior6: 70% quand la corticoth6rapie fut entreprise avant le choc, 60% lorsque les st6roides furent inject6s au moment ou le choc fut provoqu6.
Le choc est susceptible d'etre jugul6 seulement par l'administration prdcoce de corticoides et par un apport liquidien important; telle est la conclusion des auteurs.
Resumen
E1 tratamiento 6ptimo del shock s6ptico sigue siendo motivo de controversia. Con el objeto de evaluar la eficacia de la resucitaci6n con liquido y la administraci6n de corticoesteroides, se acomet/o el siguiente estudio experimental. Cuarenta y cinco cachorros (1.6-5.4 kg) fueron divididos al azar en 9 grupos generados por la combinaci6n de 3 diferentes regfmenes de l/quidos y 3 diferentes programas para la administraci6n de esteroides. El cateterismo arterial, venoso y de arteria pulmonar permiti6 la monitorfa continua hemodin~mica y metab61ica. El shock s6ptico fue inducido mediante la infusi6n lenta de un bolo de 109/kg de microorganismos E. coli. Se administr6 metilprednisolona (30 mg/kg) 30 minutos antes de la infusi6n bacteriana, o en el momento del shock, o 30 minutos despu6s del shock. Una vez que el d6bito cardiaco hubo descendido a menos del 50% de los valores de control, uno de tres reg/menes de resucitaci6n fue iniciado: albtimina al 5% en lactato de Ringer (LR) a raz6n de 35% del volumen sangufneo estimado (VSE), LR a raz6n de 105% VSE, o albfimina al 5% en LR a raz6n de 105% VSE.
A1 combinar los grupos, se vi6 que el tratamiento precoz con esteroide era mils efectivo que el tratamiento tardfo, con supervivencias respectivas de 47% y 7% a los 180 minutos. En forma similar, los grupos de resucitaci6n con volumen alto lograron 43% de supervivencia, en comparaci6n con 13% para los que fueron manejados con menor volumen de liquido. Sin embargo, ni la terapia con esteroide ni la terapia con alto volumen de liquido demostraron de por si ser capaces de aumentar la supervivencia. A pesar del pretratamiento con esteroide, ninguno de los cachorros a los que se administr6 la infusi6n de menor volumen sobrevivi6. Asf mismi, a pesar de la resucitaci6n con alto volumen de lfquido, no hubo sobrevivientes cuando 6sta fue combinada con tratamiento tardfo con esteroide (demorado por 30 minutos). $61o mediante la combinaci6n de la administraci6n precoz de esteroide con la terapia de alto volumen de liquido se logr6 una supervivencia notoriamente aumentada: 60% con el tratamiento simultfineo con esteroide, y 70% con el pretratamiento con esteroide.
En consecuencia, se demostr6 un aumento definido en la supervivencia de los animales en el perfodo agudo de shock s6ptico utilizando una combinaci6n de resucitaci6n con alto volumen de lfquido y la administraci6n precoz de esteroides.
